Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study
BackgroundPolymyxin B sulfate (PBS) and colistin sulfate (CS) are the last-line treatments for infections caused by multidrug-resistant Gram-negative bacteria, but their efficacy and safety have not been validated. The aims of the current study were to (1) determine their efficacy and safety among c...
Saved in:
Main Authors: | Yijing Zhang, Chuhui Wang, Jiaojiao Chen, Chuqi Bai, Dan Sun, Yulan Qiu, Mengmeng Teng, Yalin Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1466888/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The second life of polymyxins
by: Ageevets V.A.
Published: (2024-09-01) -
Progress in the Study of Polymyxin Heteroresistance Molecular Mechanisms
by: LI Yanbing, et al.
Published: (2024-11-01) -
Regional insights on the prevalence and antimicrobial susceptibility pattern of carbapenem and colistin-resistant gram-negative bacteria: an observational cross-sectional study from Karachi, Pakistan
by: Nazia Khursheed, et al.
Published: (2025-02-01) -
Assessment of the impact of different SARS-CoV-2 inactivation operations on colistin sulfate plasma concentration results
by: Ying-Chao Ma, et al.
Published: (2025-01-01) -
Colistin-resistance and carbapenemase-producing among carbapenem-resistance E. coli and K. pneumoniae
by: Ngá»c BÃch Trần, et al.
Published: (2024-07-01)